# Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF)

> **NCT06169540** · — · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 90 (estimated)

## Conditions studied

- CHF
- ADHF
- Control

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06169540
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-19
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06169540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06169540, "Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06169540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*